gene

BCL2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BCL2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2857Connections
0Hypotheses
3Analyses
50Outgoing
50Incoming
0Experiments
11Debates

Summary

B-cell lymphoma 2 - anti-apoptotic protein critical for neuronal survival in neurodegeneration

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolBCL2
AliasesB-cell lymphoma 2
Protein FamilyBCL-2 family (anti-apoptotic subfamily)
FunctionDirect BAX/BAK inhibition
Molecular Weight26 kDa
PathwaysAkt, Apoptosis, Autophagy, BMP signaling, Bh4 Domain
UniProt IDP10415
GeneCardsBCL2
Human Protein AtlasBCL2
BH3 domainRequired for interaction with pro-apoptotic family members
Transmembrane domainAnchors BCL2 to the outer mitochondrial membrane, ER, and nuclear envelope
BH1 domainForms part of the hydrophobic pocket that binds BH3 domains
BH2 domainContributes to the binding interface for pro-apoptotic proteins
N-terminal flexible regionContains regulatory sequences
PhosphorylationBCL2 is phosphorylated on multiple serine/threonine residues
Associated DiseasesAD, Aging, ALI, Als, Alzheimer
Known Drugs/CompoundsAbt263, ABT263, ABT-737, Adcs, berberine, BERBERINE
InteractionsABCD3, ABP, ACETYL-COA, ACHE, Actin, AD
KG Connections2852 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING
🔮 Predicted Structure: BCL2 — AlphaFold P10415 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (17)

Knowledge base pages for this entity

Canonical Page

BCL2 Gene

gene · 1851 words

BOK — BCL2 Family Ovarian Killer

gene · 2284 words

BBC3 — BCL2 Binding Component 3 (PUMA)

gene · 2006 words

BCL2L2 Gene

gene · 1124 words

BCL2L12 Gene

gene · 1024 words

BCL2 (B-Cell Lymphoma 2)

protein · 1013 words

Pathway Diagram

graph TD
    BCL2["BCL2"] -->|"expressed in"| MITOCHONDRIA["MITOCHONDRIA"]
    BCL2["BCL2"] -.->|"inhibits"| BECN1["BECN1"]
    BCL2["BCL2"] -->|"interacts"| Dementia["Dementia"]
    BCL2["BCL2"] -->|"interacts"| Cardiovascular["Cardiovascular"]
    BCL2["BCL2"] -->|"interacts"| Als["Als"]
    BCL2["BCL2"] -->|"interacts"| Alzheimer["Alzheimer"]
    STAT3["STAT3"] -->|"regulates"| BCL2["BCL2"]
    BMAL1["BMAL1"] -->|"regulates"| BCL2["BCL2"]
    CAT["CAT"] -->|"interacts"| BCL2["BCL2"]
    OPTN["OPTN"] -->|"interacts"| BCL2["BCL2"]
    style BCL2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (1923)

TargetRelationTypeStr
BCL2encodesprotein0.00
CASP3associated_withgene1.00
Alsactivatesdisease1.00
Cancerregulatesdisease1.00
Canceractivatesdisease1.00

Incoming (934)

SourceRelationTypeStr
BCL2encodesgene0.00
APOPTOSIStherapeutic_targetgene1.00
ALZHEIMER'S DISEASEassociated_withdisease1.00
APOPTOSISassociated_withgene1.00
TP53interacts_withprotein1.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.699

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 15 hypotheses Top: 0.822

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (11)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP-Mediated Complement Cascade Amplification

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

The abstract claims C. butyricum-GLP-1 crosses the BBB and binds to GLP-1 recept

closed · Rounds: 4 · Score: 0.95 · 2026-04-15

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

Related Research

Hypotheses and analyses mentioning BCL2 in their description or question text

No additional research found